Literature DB >> 22835429

Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells.

Lin Jiang1, Zhuoan Cheng, Shaobo Qiu, Zujun Que, Wenjing Bao, Chao Jiang, Fangyuan Zou, Ping Liu, Jianwen Liu.   

Abstract

Myasthenia gravis (MG) is a T cell-dependent and B cell-mediated autoimmune disease of neuromuscular junctions and cytokines may play a crucial role in the pathogenesis and perpetuation of MG. MicroRNAs (miRNAs) have been implicated as fine-tuning regulators controlling diverse biological processes at the level of posttranscriptional repression. Dysregulation of miRNAs has been described in various disease states. In this study, miRNA microarrays identified let-7 family to be decreased in peripheral blood mononuclear cells (PBMCs) from MG patients compared to the healthy controls. We next demonstrated the differential expression of let-7 family in larger samples by quantitative real-time PCR. Using a combination of bioinformatics and molecular approaches, we confirmed IL-10 as a target for let-7c. IL-10 expression also showed a negative correlation with let-7c expression in PBMCs from MG patients. Further experiments revealed that induced levels of IL-10 were inversely related to let-7c levels. We also showed that let-7c could regulate IL-10 expression in Jurkat cells. In summary, our results suggest that abnormal expression/regulation of microRNAs may contribute to or be indicative of the initiation and progression of MG.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835429     DOI: 10.1016/j.intimp.2012.07.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  22 in total

1.  Is the IL-10 -819 polymorphism associated with visceral leishmaniasis?

Authors:  Mehrdad Hajilooi; Kosro Sardarian; Maryam Dadmanesh; Mohamad Matini; Pegah Lotfi; Ahad Bazmani; Mohammad Amin Tabatabaiefar; Mohammad Kazemi Arababadi; Mohammad Momeni
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 2.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

3.  MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine.

Authors:  Wei-Bin Lin; Meng-Ya Liang; Guang-Xian Chen; Xiao Yang; Han Qin; Jian-Ping Yao; Kang-Ni Feng; Zhong-Kai Wu
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

4.  MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1.

Authors:  Zhuoan Cheng; Shaobo Qiu; Lin Jiang; Anle Zhang; Wenjing Bao; Ping Liu; Jianwen Liu
Journal:  J Clin Immunol       Date:  2012-11-30       Impact factor: 8.317

5.  Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis.

Authors:  Yuze Cao; Jianjian Wang; Huixue Zhang; Qinghua Tian; Lixia Chen; Shangwei Ning; Peifang Liu; Xuesong Sun; Xiaoyu Lu; Chang Song; Shuai Zhang; Bo Xiao; Lihua Wang
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

6.  Transcriptome markers of viral persistence in naturally-infected andes virus (bunyaviridae) seropositive long-tailed pygmy rice rats.

Authors:  Corey L Campbell; Fernando Torres-Perez; Mariana Acuna-Retamar; Tony Schountz
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

7.  miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice.

Authors:  Lei Shi; Tiantian Liu; Min Zhang; Yapei Guo; Changdong Song; Dandan Song; Hengfang Liu
Journal:  Med Sci Monit       Date:  2015-06-19

8.  Is the polymorphism at position -1082 of IL-10 gene associated with visceral leishmaniasis?

Authors:  Mehrdad Hajilooi; Alireza Ahmadi; Pegah Lotfi; Mohammad Matini; Davood Jafari; Ahad Bazmani; Mohammad Momeni
Journal:  Iran J Public Health       Date:  2014-08       Impact factor: 1.429

9.  Analysis of serum miRNA profiles of myasthenia gravis patients.

Authors:  Gisela Nogales-Gadea; Alba Ramos-Fransi; Xavier Suárez-Calvet; Miquel Navas; Ricard Rojas-García; Jose Luis Mosquera; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Isabel Illa
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

10.  Clinical Study of Effects of Jian Ji Ning, a Chinese Herbal Medicine Compound Preparation, in Treating Patients with Myasthenia Gravis via the Regulation of Differential MicroRNAs Expression in Serum.

Authors:  Chao Jiang; Ping Liu; Jingsheng Zhang; Wenjing Bao; Shaobo Qiu; Yan Liang; Lin Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.